Key Takeaways KLOW combines four peptides for a powerful, synergistic effect : Unlike single-peptide therapies that target one issue, KLOW's blend works as a team to reduce inflammation, repair tissue, and support cellular health simultaneously, creating a more comprehensive healing response
We also offer bulk purchasing options including 25-packs and case quantities for healthcare facilities with routine bacteriostatic water requirements
Niechcial A, Schwarzfischer M, Wawrzyniak M, Atrott K, Laimbacher A, Morsy Y, et al
The recombinant human GLP-1(7-36) [RhGLP-1 (7-36)], a biosynthetic agent belonging to the GLP-1 RAs, is also applied to treat T2DM clinically
Our exclusive delivery system bypasses GI barriers and floods the body with bioavailable glutathione